2024-05-21  9:59:58 PM Chg. +0.42 Volume Bid- Ask- High Low
10.98USD +3.98% 4,875
Turnover: 53,380.25
-Bid Size: - -Ask Size: - 11.48 10.54

Business description

Boundless Bio is the company dedicated to treating oncogene amplified cancers and is the leader in the field of ecDNA, driving the discovery and development of a novel therapeutic approach to targeting oncogene amplified cancers.
 

Management board & Supervisory board

CEO
Zachary Hornby
Management board
Jami Rubin, Neil Abdollahian, Amy Berkley, Chris Hassig, David Hinkle, Shailaja Kasibhatla, Peter Krein, Jessica Oien, Anthony “Tony” Pinkerton, Klaus Wagner, Meredith Wesley, Sara Weymer
Supervisory board
Jonathan Lim, Christine Brennan, Kristina Burow, James “Jamie” Christensen,, Zachary Hornby, Jennifer Lew, Nancy Whiting
 

Company data

Name: Boundless Bio Inc.
Address: 9880 Campus Point Dr, Suite 120,San Diego, CA 92121
Phone: 858-766-9912
Fax: -
E-mail: partnerships@boundlessbio.com
Internet: https://boundlessbio.com/
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 12-31
Free Float: -
IPO date: 2024-03-28

Investor relations

Name: -
IR phone: -
IR Fax: -
IR e-mail: investors@boundlessbio.com

Main Shareholders